BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17374335)

  • 1. [Kaposi's sarcoma treated with topical alitretinoin].
    González de Arriba A; Pérez-Gala S; Goiriz-Valdés R; Ríos-Buceta L; García-Díez A
    Actas Dermosifiliogr; 2007; 98(1):50-3. PubMed ID: 17374335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alitretinoin (Panretin) gel 0.1%.
    Rhoads J
    J Assoc Nurses AIDS Care; 2001; 12(5):86-91. PubMed ID: 11565242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase III vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi's sarcoma.
    Bodsworth NJ; Bloch M; Bower M; Donnell D; Yocum R;
    Am J Clin Dermatol; 2001; 2(2):77-87. PubMed ID: 11705307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical 0.1% alitretinoin gel for classic Kaposi sarcoma.
    Morganroth GS
    Arch Dermatol; 2002 Apr; 138(4):542-3. PubMed ID: 11939830
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel. Panretin Gel North American Study Group.
    Walmsley S; Northfelt DW; Melosky B; Conant M; Friedman-Kien AE; Wagner B
    J Acquir Immune Defic Syndr; 1999 Nov; 22(3):235-46. PubMed ID: 10770343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment.
    Dezube BJ
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):193-200. PubMed ID: 12113241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials.
    Duvic M; Friedman-Kien AE; Looney DJ; Miles SA; Myskowski PL; Scadden DT; Von Roenn J; Galpin JE; Groopman J; Loewen G; Stevens V; Truglia JA; Yocum RC
    Arch Dermatol; 2000 Dec; 136(12):1461-9. PubMed ID: 11115156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaposi's sarcoma: new topical treatment approved.
    James JS
    AIDS Treat News; 1999 Feb; (No 313):1. PubMed ID: 11366235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classic Kaposi's sarcoma treated with topical 0.5% timolol gel.
    Alcántara-Reifs CM; Salido-Vallejo R; Garnacho-Saucedo GM; Vélez García-Nieto A
    Dermatol Ther; 2016 Sep; 29(5):309-311. PubMed ID: 27329079
    [No Abstract]   [Full Text] [Related]  

  • 10. Antitumor activity of oral 9-cis-retinoic acid in HIV-associated Kaposi's sarcoma.
    Miles SA; Dezube BJ; Lee JY; Krown SE; Fletcher MA; Saville MW; Kaplan L; Groopman J; Scadden DT; Cooley T; Von Roenn J; Friedman-Kien A;
    AIDS; 2002 Feb; 16(3):421-9. PubMed ID: 11834954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alitretinoin.
    Cheer SM; Foster RH
    Am J Clin Dermatol; 2000; 1(5):307-14; discussion 315-6. PubMed ID: 11702321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi's sarcoma following allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia.
    de Medeiros BC; Rezuke WN; Ricci A; Tsongalis G; Shen PU; Bona RD; Feingold JM; Edwards RL; Tutschka PJ; Bilgrami S
    Acta Haematol; 2000; 104(2-3):115-8. PubMed ID: 11154986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classic Kaposi's sarcoma: low-dose interferon alfa treatment.
    Tur E; Brenner S
    Dermatology; 1998; 197(1):37-42. PubMed ID: 9693183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of AIDS-associated Kaposi's sarcoma with oral tretinoin.
    Bonhomme L; Fredj G; Ecstein E; Maurisson G; Farabos C; Misset JL; Jasmin C
    Am J Hosp Pharm; 1994 Oct; 51(19):2417-9. PubMed ID: 7847408
    [No Abstract]   [Full Text] [Related]  

  • 15. Topical imiquimod 5% as a treatment for localized genital Kaposi's sarcoma in an HIV-negative man: a case report.
    Fairley JL; Denham I; Yoganathan S; Read TR
    Int J STD AIDS; 2012 Dec; 23(12):907-8. PubMed ID: 23258836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIDS-related Kaposi sarcoma: the role of local therapy for a systemic disease.
    Dezube BJ
    Arch Dermatol; 2000 Dec; 136(12):1554-6. PubMed ID: 11115173
    [No Abstract]   [Full Text] [Related]  

  • 17. Failure of topical 0.1% alitretinoin gel for classic Kaposi sarcoma: first European experience.
    Rongioletti F; Zaccaria E; Viglizzo G
    Br J Dermatol; 2006 Oct; 155(4):856-7. PubMed ID: 16965450
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not".
    Volkow P; Zinser JW; Correa-Rotter R
    BMC Nephrol; 2007 Mar; 8():6. PubMed ID: 17386117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study.
    Gill PS; Espina BM; Moudgil T; Kidane S; Esplin JA; Tulpule A; Levine AM
    Leukemia; 1994; 8 Suppl 3():S26-32. PubMed ID: 7808021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited extent AIDS-related cutaneous Kaposi's sarcoma responsive to imiquimod 5% cream.
    Rosen T
    Int J Dermatol; 2006 Jul; 45(7):854-6. PubMed ID: 16863526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.